Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.4K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.4K
Cancer02:18

Cancer

51.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.5K
Cancer Vaccines01:30

Cancer Vaccines

602
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
602
Humoral Immune Responses01:36

Humoral Immune Responses

79.4K
Overview
79.4K
Cancer Prevention02:59

Cancer Prevention

7.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.2K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

3.1K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CNS relapse during menin inhibitor therapy.

Blood·2026
Same author

Mediator subunit MED4 enforces metastatic dormancy in breast cancer.

Nature cell biology·2026
Same author

Bendamustine/Rituximab Induction Followed by Venetoclax/Rituximab Consolidation in Frontline Treatment of Chronic Lymphocytic Leukemia: A Phase 2 Multi-Center Study.

Hematological oncology·2026
Same author

Stag2 dependent chromatin remodeling enforces the erythroid-specific Gata1 cistrome.

Blood·2026
Same author

Metadomain and metaloop genome interactions in mammalian T cells.

Cell reports·2026
Same author

Treatment-emergent coagulopathy during azacitidine/venetoclax induction in AML.

Blood neoplasia·2026

Related Experiment Video

Updated: Nov 6, 2025

Ole Isacson: Development of New Therapies for Parkinson's Disease
23:53

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

8.1K

A physician-scientist's call to arms.

Aaron D Viny1

  • 1Department of Medicine, Division of Hematology & Oncology, Columbia University Irving Medical Center, New York, NY, USA; Columbia Stem Cell Initiative, Columbia University Irving Medical Center, New York, NY, USA; Department of Genetics & Development, Columbia University Irving Medical Center, New York, NY, USA.

Cell Stem Cell
|May 7, 2021
PubMed
Summary
This summary is machine-generated.

Physician-scientists faced significant emotional distress during the COVID-19 pandemic. Continued vaccination efforts and mutual support are crucial for navigating the ongoing public health crisis.

More Related Videos

Using Micro-Electro-Mechanical Systems MEMS to Develop Diagnostic Tools
16:05

Using Micro-Electro-Mechanical Systems MEMS to Develop Diagnostic Tools

Published on: October 1, 2007

7.7K
Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

6.0K

Related Experiment Videos

Last Updated: Nov 6, 2025

Ole Isacson: Development of New Therapies for Parkinson's Disease
23:53

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

8.1K
Using Micro-Electro-Mechanical Systems MEMS to Develop Diagnostic Tools
16:05

Using Micro-Electro-Mechanical Systems MEMS to Develop Diagnostic Tools

Published on: October 1, 2007

7.7K
Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

6.0K

Area of Science:

  • Medical Research
  • Pandemic Response
  • Physician-Scientist Well-being

Background:

  • The COVID-19 pandemic has profoundly impacted the scientific community, particularly early-career researchers.
  • Cell Stem Cell has featured personal stories of researchers affected by pandemic-related disruptions.
  • This piece reflects on the experiences of physician-scientists one year into the pandemic.

Purpose of the Study:

  • To highlight the emotional toll experienced by physician-scientists during the COVID-19 pandemic.
  • To emphasize the importance of vaccination and community support in overcoming the crisis.
  • To provide a personal perspective on the challenges faced by medical researchers.

Main Methods:

  • Qualitative reflection on personal experiences.
  • Narrative sharing of challenges and coping mechanisms.
  • Expert commentary on the pandemic's impact on physician-scientists.

Main Results:

  • Physician-scientists have endured substantial emotional distress and professional challenges.
  • The pandemic has underscored the critical need for robust public health measures, including vaccination.
  • Interpersonal support and collaboration are vital for resilience during health crises.

Conclusions:

  • Addressing the mental health of physician-scientists is essential for sustained research productivity.
  • Vaccination remains a cornerstone of pandemic control and a pathway to recovery.
  • Community and mutual support are indispensable for navigating prolonged public health emergencies.